Company news
Beijing Biostar Pharmaceuticals Co., Ltd. news in 2026
Beijing Biostar Pharmaceuticals Co., Ltd.'s news releases, calls and decks from 2026, newest first.
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
November 3, 2026
Voluntary announcement - UTD2 of biostar achieves first patient dosing in phase III clinical study for HER2-negative advanced breast cancer
October 20, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
October 7, 2026
Interim Report 2026
September 22, 2026